PEGylated Tween 80-functionalized chitosan-lipidic nano-vesicular hybrids for heightening nose-to-brain delivery and bioavailability of metoclopramide

References

• Abaee A, Madadlou A. (2016). Niosome-loaded cold-set whey protein hydrogels. Food Chem 196:1–21.
   PubMed Web of Science ®Google Scholar
• Abdelbary AA, Aboughaly MHH. (2015). Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis : application of Box – Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm 485:235–43.
   PubMed Web of Science ®Google Scholar
• Abdelbary G, El-gendy N. (2008). Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech 9:740–7.
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Ismail S, Kamal A, Alany RG. (2011). Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci 99:1833–46.
   Google Scholar
• Abdelmonem R, Elhabal SF, Abdelmalak NS, et al. (2021). Formulation and characterization of acetazolamide/carvedilol niosomal gel for glaucoma treatment: in vitro, and in vivo study. Pharmaceutics 13:221.
   PubMed Web of Science ®Google Scholar
• Abdulkarim M, Agulló N, Cattoz B, et al. (2015). Nanoparticle diffusion within intestinal mucus: three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles. Eur J Pharm Biopharm 97:230–8.
   PubMed Web of Science ®Google Scholar
• Abo-EL-Sooud K. (2018). Absolute and relative bioavailability. In: Hock FJ, Gralinski MR, eds. Drug discovery and evaluation: methods in clinical pharmacology. Cham: Springer International Publishing, 1–7.
   Google Scholar
• Ahmed TA, El-Say KM, Ahmed OAA, Aljaeid BM. (2019). Superiority of tpgs-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel. Int J Nanomed 14:5555–67.
   PubMed Web of Science ®Google Scholar
• Allen JC, Gralla R, Reilly L, et al. (1985). Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy. J Clin Oncol 3:1136–41.
   PubMed Web of Science ®Google Scholar
• Arafa MG, Ayoub BM. (2017). DOE optimization of nano-based carrier of pregabalin as hydrogel: new therapeutic & chemometric approaches for controlled drug delivery systems. Sci Rep 7:41503–15.
   PubMed Web of Science ®Google Scholar
• Bayindir ZS, Yuksel N. (2010). Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 99:2049–60.
   PubMed Web of Science ®Google Scholar
• Bendas ER, Abdullah H, El-Komy MHM, Kassem MAA. (2013). Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus. Int J Pharm 458:287–95.
   PubMed Web of Science ®Google Scholar
• Chen S, Hanning S, Falconer J, et al. (2019). Recent advances in non-ionic surfactant vesicles (niosomes): fabrication, characterization, pharmaceutical and cosmetic applications. Eur J Pharm Biopharm 144:18–39.
   PubMed Web of Science ®Google Scholar
• Claudio P, Reatul K, Brigitte E, Geraldine P. (2016). Drug-delivery nanocarriers to cross the blood–brain barrier. In: Grumezescu AM, ed. Nanobiomaterials in Drug Delivery. 9th ed. Oxford: Elsevier, 333–70.
   Google Scholar
• Danhier F, Lecouturier N, Vroman B, et al. (2009). Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release 133:11–7.
   PubMed Web of Science ®Google Scholar
• Delrat P, Paraire M, Jochemsen R. (2002). Complete bioavailability and lack of food-effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers. Biopharm Drug Dispos 23:151–7.
   PubMed Web of Science ®Google Scholar
• Denora N, Trapani A, Laquintana V, et al. (2009). Recent advances in medicinal chemistry and pharmaceutical technology- strategies for drug delivery to the brain. Curr Top Med Chem 9:182–96.
   PubMed Web of Science ®Google Scholar
• Desoqi MH, El-sawy HS, Kafagy E, et al. (2021). Fluticasone propionate – loaded solid lipid nanoparticles with augmented anti-inflammatory activity : optimisation, characterisation and pharmacodynamic evaluation on rats. J Microencapsul 38:177–91.
   PubMed Web of Science ®Google Scholar
• ELhabal SF, Elwy HM, Hassanin S, et al. (2022). Biosynthesis and characterization of gold and copper nanoparticles from salvadora persica fruit extracts and their biological properties. Int J Nanomed 17:6095–112.
   PubMed Web of Science ®Google Scholar
• El-Nabarawi MA, Bendas ER, El Rehem RTA, Abary MYS. (2013). Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability. Int J Pharm 443:307–17.
   PubMed Web of Science ®Google Scholar
• El-Ridy MS, Abdelbary A, Essam T, et al. (2011). Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. Drug Dev Ind Pharm 37:1491–508.
   PubMed Web of Science ®Google Scholar
• El-Say KM, El-Helw A-R, Ahmed OAAA, et al. (2015). Statistical optimization of controlled release microspheres containing cetirizine hydrochloride as a model for water soluble drugs. Pharm Dev Technol 20:738–46.
   PubMed Web of Science ®Google Scholar
• El-Say KM, Abd-Allah FI, Lila AE, et al. (2016). Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment. J Liposome Res 26:57–68.
   PubMed Web of Science ®Google Scholar
• Gajra B, Dalwadi C, Patel R. (2015). Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using Box Behnken design. DARU J Pharm Sci 23:1–15.
   Web of Science ®Google Scholar
• Gänger S, Schindowski K. (2018). Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics 10:116.
   PubMed Web of Science ®Google Scholar
• Gardouh AR, Ewedah TM, Abd-Allah FI, et al. (2021). Enhanced efficacy, cellular uptake, and antiangiogenic activity of the optimized imatinib mesylate-loaded proniosomal-derived nanovesicles. J Drug Deliv Sci Technol 61:102267.
   Web of Science ®Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. (2005). Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 306:71–82.
   PubMed Web of Science ®Google Scholar
• Gurrapu A, Jukanti R, Bobbala SR, et al. (2012). Improved oral delivery of valsartan from maltodextrin based proniosome powders. Adv Powder Technol 23:583–90.
   Web of Science ®Google Scholar
• Hamza AA, Khasawneh MA, Elwy HM, et al. (2022). Salvadora persica attenuates DMBA-induced mammary cancer through downregulation oxidative stress, estrogen receptor expression and proliferation and augmenting apoptosis. Biomed Pharmacother 147:112666.
   PubMed Web of Science ®Google Scholar
• Hassanzadeganroudsari M, Heydarinasab A, Akbarzadeh khiyavi A, et al. (2019). In vitro investigation of anticancer efficacy of carboplatin-loaded PEGylated nanoliposome particles on brain cancer cell lines. J Nanopart Res 21:124.
   Web of Science ®Google Scholar
• Herrstedt J, Lindberg S, Petersen PC. (2022). Prevention of chemotherapy-induced nausea and vomiting in the older patient: optimizing outcomes. Drugs Aging 39:1–21.
   PubMed Web of Science ®Google Scholar
• Jana U, Mohanty AK, Pal SL, et al. (2014). Felodipine loaded PLGA nanoparticles: preparation, physicochemical characterization and in vivo toxicity study. Nano Converg 1:31.
   Google Scholar
• Jonkman JH, van der Boon WJ, Schoenmaker R, et al. (1984). The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets. Int J Clin Pharmacol Ther Toxicol 22:506–10.
   PubMedGoogle Scholar
• Kassem MA, El-Sawy HS, Abd-Allah FI, et al. (2017). Maximizing the therapeutic efficacy of imatinib mesylate–loaded niosomes on human colon adenocarcinoma using Box-Behnken design. J Pharm Sci 106:111–22.
   PubMed Web of Science ®Google Scholar
• Kaur G, Mehta SK. (2017). Developments of Polysorbate (Tween) based microemulsions: preclinical drug delivery, toxicity and antimicrobial applications. Int J Pharm 529:134–60.
   PubMedGoogle Scholar
• Kumar GP, Rajeshwarrao P. (2011). Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B 1:208–19.
   Web of Science ®Google Scholar
• Kumar S, Sangwan P, Lather V, Pandita D. (2015). Biocompatible PLGA-oil hybrid nanoparticles for high loading and controlled delivery of resveratrol. J Drug Deliv Sci Technol 30:54–62.
   Web of Science ®Google Scholar
• Laffleur F, Bauer B. (2021). Progress in nasal drug delivery systems. Int J Pharm 607:120994.
   PubMedGoogle Scholar
• Lee A, Kuo B. (2010). Metoclopramide in the treatment of diabetic gastroparesis. Expert Rev Endocrinol Metab 5:653–62.
   PubMedGoogle Scholar
• Li Q, Li Z, Zeng W, et al. (2014). Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. Eur J Pharm Sci 62:115–23.
   PubMed Web of Science ®Google Scholar
• Li W-Z, Hao X-L, Zhao N, et al. (2016). Propylene glycol-embodying deformable liposomes as a novel drug delivery carrier for vaginal fibrauretine delivery applications. J Control Release 226:107–14.
   PubMed Web of Science ®Google Scholar
• Mahajan HS, Gattani S. (2010). In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits. Drug Deliv 17:19–27.
   PubMed Web of Science ®Google Scholar
• Mahmoud MO, Aboud HM, Hassan AH, et al. (2017). Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats. J Control Release 254:10–22.
   PubMed Web of Science ®Google Scholar
• Marianecci C, Paolino D, Celia C, et al. (2010). Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. J Control Release 147:127–35.
   PubMed Web of Science ®Google Scholar
• Marianecci C, Rinaldi F, Di Marzio L, et al. (2014). Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models. Int J Nanomedicine 9:635–51.
   PubMed Web of Science ®Google Scholar
• Marianecci C, Rinaldi F, Mastriota M, et al. (2012). Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine models. J Control Release 164:17–25.
   PubMed Web of Science ®Google Scholar
• Megahed MA, El-Sawy HS, Reda AM, et al. (2022). Effect of nanovesicular surface-functionalization via chitosan and/or PEGylation on cytotoxicity of tamoxifen in induced-breast cancer model. Life Sci 307:120908.
   PubMed Web of Science ®Google Scholar
• Mehta SK, Jindal N. (2013). Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs. Colloids Surf B Biointerfaces 101:434–41.
   PubMed Web of Science ®Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, Megrab NA. (2008). Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361:104–11.
   PubMed Web of Science ®Google Scholar
• Mujtaba A, Ali M, Kohli K. (2014). Statistical optimization and characterization of pH-independent extended-release drug delivery of cefpodoxime proxetil using Box-Behnken design. Chem Eng Res Des 92:156–65.
   Web of Science ®Google Scholar
• Mulik RS, Mönkkönen J, Juvonen RO, et al. (2012). ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells. Int J Pharm 437:29–41.
   PubMed Web of Science ®Google Scholar
• Nasr M, Mansour S, Mortada ND, Elshamy AA. (2008). Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul 25:499–512.
   PubMed Web of Science ®Google Scholar
• Nugraha YP, Uekusa H. (2018). Suppressed hydration in metoclopramide hydrochloride by salt cocrystallisation. CrystEngComm 20:2653–62.
   Web of Science ®Google Scholar
• Nukulkit C, Priprem A, Damrongrungruang T, et al. (2014). N. Effect of polycaprolactone on in vitro release of melatonin encapsulated niosomes in artificial and whole saliva. J Drug Deliv Sci Technol 24:153–8.
   Web of Science ®Google Scholar
• Pardakhty A, Varshosaz J, Rouholamini A. (2007). In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 328:130–41.
   PubMed Web of Science ®Google Scholar
• Pasricha PJ, Pehlivanov N, Sugumar A, Jankovic J. (2006). Drug Insight: from disturbed motility to disordered movement - a review of the clinical benefits and medicolegal risks of metoclopramide. Nat Rev Gastroenterol Hepatol 3:138–48.
   Google Scholar
• Pero RW, Olsson A, Simanaitis M, et al. (1997). Pharmacokinetics, toxicity, side effects, receptor affinities and in vitro radiosensitizing effects of the novel metoclopramide formulations, sensamide and neu-sensamide. Pharmacol Toxicol 80:231–9.
   PubMedGoogle Scholar
• Radwan MA. (2001). Preparation and in vivo evaluation of parenteral metoclopramide-loaded poly(alkylcyanoacrylate) nanospheres in rats. J Microencapsul 18:467–77.
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. (2008). Dose translation from animal to human studies revisited. FASEB J 22:659–61.
   PubMed Web of Science ®Google Scholar
• Ruckmani K, Sankar V. (2010). Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech 11:1119–27.
   PubMed Web of Science ®Google Scholar
• Sahoo RK, Biswas N, Guha A, et al. (2014). Development and in vitro/in vivo evaluation of controlled release provesicles of a nateglinide – maltodextrin complex. Acta Pharm Sin B 4:408–16.
   PubMed Web of Science ®Google Scholar
• Sayyed ME, El-Motaleb MA, Ibrahim IT, et al. (2022). Preparation, characterization, and in vivo biodistribution study of intranasal 131I-clonazepam-loaded phospholipid magnesome as a promising brain delivery system: biodistribution and pharmacokinetic behavior of intranasal 131I-Clonazepam loaded phospholip. Eur J Pharm Sci 169:106089.
   PubMed Web of Science ®Google Scholar
• Schuppan D, Molz KH, Staib AH, Rietbrock N. (1981). Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)–plasma levels after single and multiple oral doses. Int J Clin Pharmacol Ther Toxicol 19:223–7.
   PubMedGoogle Scholar
• Shakhatreh M, Jehangir A, Malik Z, Parkman HP. (2019). Metoclopramide for the treatment of diabetic gastroparesis. Expert Rev Gastroenterol Hepatol 13:711–21.
   PubMed Web of Science ®Google Scholar
• Shenoy VS, Gude RP, Murthy RS. (2013). In vitro anticancer evaluation of 5-fluorouracil lipid nanoparticles using B16F10 melanoma cell lines. Int Nano Lett 3:36.
   Google Scholar
• Solanki AB, Parikh JR, Parikh RH. (2007). Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design. AAPS PharmSciTech 8:E86.
   PubMed Web of Science ®Google Scholar
• Stosik AG, Junginger HE, Kopp S, et al. (2008). Biowaiver monographs for immediate release solid oral dosage forms: metoclopramide hydrochloride. J Pharm Sci 97:3700–8.
   PubMed Web of Science ®Google Scholar
• Taweel MME, Aboul-Einien MH, Kassem MA, Elkasabgy NA. (2021). Intranasal zolmitriptan-loaded bilosomes with extended nasal mucociliary transit time for direct nose to brain delivery. Pharmaceutics 13:1828.
   PubMed Web of Science ®Google Scholar
• Tian X, Liu F, Li Z, et al. (2019). Enhanced anti-diabetic effect of berberine combined with timosaponin B2 in Goto-Kakizaki rats, associated with increased variety and exposure of effective substances through intestinal absorption. Front Pharmacol 10:19.
   PubMed Web of Science ®Google Scholar
• Waddad AY, Abbad S, Yu F, et al. (2013). Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants. Int J Pharm 456:446–58.
   PubMed Web of Science ®Google Scholar
• Wu Z, Zhang G, Pan J, et al. (2016). ‍Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Colloids Surf B Biointerfaces 141:28–35.
   PubMed Web of Science ®Google Scholar
• Yuksel N, Bayindir ZS, Aksakal E, Ozcelikay AT. (2016). In situ niosome forming maltodextrin proniosomes of candesartan cilexetil: in vitro and in vivo evaluations. Int J Biol Macromol 82:453–63.
   PubMed Web of Science ®Google Scholar
• Zaki NM, Awad GA, Mortada ND, A, ElHady SS. (2007). Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci 32:296–307.
   PubMed Web of Science ®Google Scholar
• Zaki NM, Awad GAS, Mortada ND, Abd ElHady SS. (2006a). Rapid-onset intranasal delivery of metoclopramide hydrochloride. Int J Pharm 327:89–96.
   PubMed Web of Science ®Google Scholar
• Zaki NM,  Mortada ND,  Awad GAS,  ElHady SSA.   (2006b). Rapid-onset intranasal  delivery of  metoclopramide  hydrochloride. Int J  Pharm 327:97–103.
   PubMed Web of Science ®Google Scholar